Fungistatic effects of optical brightener 220 against Trichophyton tonsurans, Aspergillus fumigatus and Candida albicans

Authors: Sadeghi, Golnar1; Khaksar, Ali Asghar1; Jahromi, Shahindokht Bassiri1; Amirkhani, Aref2; Eslamifar, Ali3; Ajdary, Soheila4; Katiraee, Farzad1; Taeb, Jaleh3; Paskiabi, Farnoosh Asghari1; Sayyah, Mohammad5

Source: Journal of Dermatological Treatment, Volume 20, Number 2, 2009 , pp. 120-123(4)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $33.39 plus tax (Refund Policy)

Abstract:

Background: Dermatophytes are one of the main causes of dermal infections. Moreover, there are some opportunistic fungi such as Aspergillus fumigatus (mycelial form) and Candida albicans (yeasty form) that in immunosuppressed patients can cause cutaneous disease. Objectives: The possible effect of optical brightener 220 (OB-220) on the growth of fungi has been evaluated in this study. Methods: Isolates were grown on agar plates containing OB-220 in concentration between 0.06 and 11.68 mg ml-1. MICs of OB-220, ketoconazole and fluconazole were obtained by the agar dilution method. Hyphae and yeasts grown with OB-220 were compared with controls by fluorescence and transmission electron microscopy. The cell cytotoxicity of OB-220 was also assessed. Results: The MIC90 of OB-220 was obtained: 1.17-1.46 mg ml-1 for A. fumigatus, 0.58-1.17 mg ml-1 for C. albicans and 0.29 mg ml-1 for Trichophyton tonsurans. Electron microscopy revealed a thickening and blurred contours of the cell wall by OB-220. OB-220 in concentrations up to 11.68 mg ml-1 posed no mammalian cell toxicity. Conclusion: OB-220 suppresses the growth of fungi by interfering with the formation of normal chitin.

Keywords: Chitin; fungistatic effect; OB-220

Document Type: Research article

DOI: http://dx.doi.org/10.1080/09546630802449070

Affiliations: 1: Department of Mycology, Pasteur Institute of Iran, Tehran, Iran 2: Department of Epidemiology, Pasteur Institute of Iran, Tehran, Iran 3: Department of Clinical Research, Pasteur Institute of Iran, Tehran, Iran 4: Department of Immunology, Pasteur Institute of Iran, Tehran, Iran 5: Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran

Publication date: 2009-01-01

More about this publication?

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page